Gerd Kochendoerfer
Operationeel Directeur bij NFlection Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Gerd Kochendoerfer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
NFlection Therapeutics, Inc.
 NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.
7
| Holding Company | Biotechnology | 7 |
| Public Company | Pharmaceuticals: Major | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gerd Kochendoerfer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| LAM RESEARCH CORPORATION | Industrial Machinery | Human Resources Officer | |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Pharmaceuticals: Major | General Counsel | |
| ROCKWELL MEDICAL, INC. | Medical Specialties | Chief Executive Officer | |
| CORMEDIX INC. | Biotechnology | Chairman | |
Vicept Therapeutics, Inc.
 Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Founder | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
| Stanford University | College/University | Graduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal | |
| Immaculata University | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree | |
| Georgetown University | College/University | Doctorate Degree | |
| London School of Hygiene & Tropical Medicine | College/University | Graduate Degree | |
| The State University of New York | College/University | Undergraduate Degree | |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
ProSanos Corp.
 ProSanos Corp. Medical/Nursing ServicesHealth Services ProSanos Corp. develops and provides healthcare solutions for the pharmaceutical and biotechnology industries. The company was founded by Jonathan A. Morris and Michael N. Liebman in 2000 and is headquartered in Harrisburg, PA. | Medical/Nursing Services | Director/Board Member | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Chief Tech/Sci/R&D Officer | |
The Independent Institute
 The Independent Institute Miscellaneous Commercial ServicesCommercial Services The Independent Institute is a non-profit public-policy research and educational organization which shapes ideas through publications, conferences, and multi-media programs. It offers course adoption program, working papers, research articles, audio and visual programs, and student internships and seminars. The organization was founded by David J. Theroux in 1986 and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Medical School | College/University | Graduate Degree | |
| Dartmouth Medical School | College/University | Doctorate Degree | |
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Investment Managers | Director/Board Member | |
| Wyeth Laboratories, Inc. | Corporate Officer/Principal | ||
Rockwell Transportation, Inc.
 Rockwell Transportation, Inc. Air Freight/CouriersTransportation Rockwell Transportation, Inc. engages in arrangement of freight and cargo transportation services. The company is headquartered in Wixom, MI. | Air Freight/Couriers | President | |
| Stanford Law School | College/University | Graduate Degree | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Chromaderm, Inc.
 Chromaderm, Inc. BiotechnologyHealth Technology Chromaderm, Inc. operates as a clinical stage biotech company. It develops topical PKC-beta inhibitor. The company was founded by Barbara A. Gilchrest, Mark de Souza and James W. Fordyce and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| ICHOR HOLDINGS, LTD. | Industrial Machinery | Director/Board Member | |
FIBRX Derm, Inc.
 FIBRX Derm, Inc. Pharmaceuticals: MajorHealth Technology FIBRX Derm, Inc. develops anti-scarring therapeutic for patients with Dystrophic Epidermolysis Bullosa. The company was founded by Mark de Souza, James W. Fordyce and Erkki Ruoslahti and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Founder | |
SeylanMED LLC
 SeylanMED LLC Miscellaneous Commercial ServicesCommercial Services SeylanMED LLC operates as a private biopharmaceutical company that develops a targeted therapy for Seborrheic Keratosis. The company as founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
FibroGen (China) Medical Technology Development Co. Ltd.
 FibroGen (China) Medical Technology Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FibroGen, Inc., FibroGen (China) Medical Technology Development Co., Ltd. is a biomedical technology company based in Beijing, China. FibroGen () is dedicated to developing new mechanisms of action or "best-in-class" innovative drugs and medical devices to meet the unmet clinical needs of Chinese patients. The Chinese company also provides a platform to report adverse events related to FibroGen roxadustat products. The company was founded in 2011. Christine Chung L. has been the CEO of the company since 2019. | Pharmaceuticals: Major | Chief Executive Officer | |
Bond Biosciences, Inc.
 Bond Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Bond Biosciences, Inc. engages in healthcare business. It focuses on small developing molecule based therapeutics for preventing iron absorption. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
| Alameda Consulting LLC | Corporate Officer/Principal | ||
Alexo Therapeutics International
 Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chairman | |
3CC Management LLC
 3CC Management LLC Investment ManagersFinance 3CC Management LLC (Third Culture Capital) is a venture capital firm founded in 2020 by Julien L. Pham. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
SonALAsense, Inc.
 SonALAsense, Inc. BiotechnologyHealth Technology SonALAsense, Inc. provides ALA Sonodynamic Therapy for the treatment of Glioblastoma Multiforme. The company was founded by Stuart Marcus and is headquartered in Berkeley, CA. | Biotechnology | Founder | |
SeylanMED, Inc.
 SeylanMED, Inc. BiotechnologyHealth Technology SeylanMED, Inc. engages in the development of topical akt inhibitor as a treatment for seborrheic keratosis. The company was founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA. | Biotechnology | Chief Executive Officer | |
| FibroGen International (Cayman) Ltd. | Director/Board Member | ||
| FibroGen International (Hong Kong) Ltd. | Director/Board Member | ||
Phoenicis Therapeutics, Inc.
 Phoenicis Therapeutics, Inc. BiotechnologyHealth Technology Phoenicis Therapeutics, Inc. is a private company that is focused on developing therapies for rare dermatological disorders. The company is based in Hingham, MA. The company's goal is to improve the lives of those who suffer from these conditions. The CEO of the company is Deborah Ramsdell. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Verenigd Koninkrijk | 2 |
| Nederland | 2 |
| China | 2 |
| Kaaimaneilanden | 2 |
Sectoraal
| Health Technology | 22 |
| Consumer Services | 13 |
| Finance | 4 |
| Producer Manufacturing | 3 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 27 |
| Corporate Officer/Principal | 22 |
| Chief Executive Officer | 18 |
| President | 10 |
| Chief Tech/Sci/R&D Officer | 8 |
Sterkste connecties
| Insiders | |
|---|---|
| Russell Ellison | 20 |
| Joshua Grass | 10 |
| William Hodder | 9 |
| Sarah O'Dowd | 9 |
| Mark de Souza | 9 |
| Christopher Powala | 7 |
| Paul J. Frohna | 7 |
| Christine Chung L. | 7 |
| Grace U. Shin | 6 |
| Kenneth Tsai | 6 |
| Corey Goodman | 3 |
| Seth Porter | 2 |
| Katen Patel | 1 |
- Beurs
- Insiders
- Gerd Kochendoerfer
- Bedrijfsconnecties
